麒麟丸治疗少弱精子症的临床研究进展  

Qilin Pills for oligoasthenospermia: Advances in clinical studies

作　　者：张开舒[1,2] 傅龙龙[1,2] 商学军 谷翊群[1,2] 

机构地区：[1]北京协和医学院研究生院,北京100730 [2]国家卫生和计划生育委员会科学技术研究所/世界卫生组织人类生殖合作研究中心男性临床研究室,北京100081 [3]南方医科大学南京临床医学院/南京军区南京总医院男科,江苏南京210002

出　　处：《中华男科学杂志》2017年第10期938-941,共4页National Journal of Andrology

基　　金：国家卫生计生委科学技术研究所科研项目(2016HX004)~~

摘　　要：随着人类工业化进程快速发展以及环境污染等情况的出现,人类生殖面临诸多困境,男性不育症患病率逐年升高,西医在治疗男性不育症,尤其是少弱精子症方面有诸多局限。祖国传统中医药在治疗少弱精子症方面历史悠久,经验丰富;形成了以中医理论为基础的大批药剂,在治疗少弱精子症方面发挥着重要作用。麒麟丸作为其中的典型代表,在治疗少弱精子症方面有显著疗效,尤其和西药联合应用疗效更加明显。目前,麒麟丸研究主要集中于临床疗效观察阶段,基础研究较少,缺乏相关机制的研究。Industrialization and environmental pollution are bringing more problems to human reproduction and increasing the prevalence of male infertility. Western medicine has shown its limitations in the management of male infertility,especially that of oligoasthenospermia. Traditional Chinese medicine（ TCM）,however,has long and rich experiences in the treatment of oligoasthenospermia,with a large variety of medicinal prescriptions based on the TCM theories,among which Qilin Pills shows a particularly significant therapeutic effect on oligoasthenospermia,especially when combined with Western medicine. At present,published studies on Qilin Pills are mainly in the stage of clinical observation,while basic researches and studies on its relevant mechanisms are rarely seen.

关 键 词：麒麟丸 男性不育 少弱精子症 生育力 

分 类 号：R277.5[医药卫生—中医学]